Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan–Treated Human Epidermal Growth Factor Receptor 2–Positive ...
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...
While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the ...
Patients with classic NF1 including the presence of cutaneous neurofibromas or Lisch nodules, as no genetic heterogeneity demonstrated so far associated with this phenotype. The NF1-only by NGS ...
Roche, a healthcare company, announced the launch of AXELIOS 1 based on the innovative SBX technology, with a unique combination of accuracy, speed, flexibility, scalability and cost efficiency that ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
It explores how long-read sequencing was used to identify a pathogenic dystrophia myotonica protein kinase (DMPK) repeat ...
Times Now World on MSN
DNA analysis of the Shroud of Turin reveals evidence of human interaction over centuries, yet its origins remain unverified
Nearly five decades post-collection of samples from the Shroud of Turin, scientists employed cutting-edge genetic sequencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results